Allergy Therapeutics Plc

Allergy Therapeutics PLC is a pharmaceutical company focused on the research, development and commercialisation of innovative allergy immunotherapy products. Its primary aim is to provide effective, patient-centric treatments that target the underlying causes of allergic diseases across different markets. Operating within the specialised healthcare sector, Allergy Therapeutics concentrates on developing subcutaneous and sublingual immunotherapies. The company aims to significantly improve the quality of life for allergy sufferers by offering long-term relief from symptoms through targeted biological treatments. Monitor the AGY.L share price by adding it to your eToro watchlist. This content was generated by artificial intelligence. We cannot guarantee the accuracy, completeness, or timeliness of the information provided.